Merck advances cancer innovation by expanding role of Keytruda across new tumor
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
BIL also holds an option to increase its equity stake by an additional 15%
The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital,
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
CRISPR-based detection enables highly specific molecular recognition
The facility has been designed with a dual focus on efficiency and sustainability
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
He has been associated with the Zydus Group since 2009
Subscribe To Our Newsletter & Stay Updated